Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check3 days agoChange DetectedThe page has updated the number of study locations from 430 to 433 and added new recruiting sites in Mexico City, Montreal, and Miami, while removing some outdated contact information.SummaryDifference1%
- Check10 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, and the revision number has changed from v2.16.3 to v2.16.4.SummaryDifference0.2%
- Check17 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 423 to 430, with several new recruiting sites added in various countries, including the United States, Canada, and Georgia. Additionally, some outdated contact information and locations have been removed.SummaryDifference2%
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check32 days agoChange DetectedThe page now indicates that the study has increased from 422 to 423 locations and has updated contact information for the Study Coordinator in Englewood, Colorado. Additionally, the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input.SummaryDifference0.6%
- Check39 days agoChange DetectedThe webpage has updated its study locations, increasing the total from 413 to 422, and has added several new recruiting sites across various countries, including Spain, Slovakia, and the United States. Additionally, some registry identifiers have been removed.SummaryDifference6%
Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.